Abstract Details
|
Kapil Gururangan, MD
(Northwestern University)
PRESENTER |
Dr. Gururangan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell Inc. Dr. Gururangan has stock in Ceribell Inc. The institution of Dr. Gururangan has received research support from NIH-NINDS. The institution of Dr. Gururangan has received research support from Leon Levy Foundation. |
| Babak Razavi, MD, PhD (Stanford University Medical Center) | Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace. |
| Rita A. Popat, PhD (Health Research Policy, Division of Epid) | No disclosure on file |